199 related articles for article (PubMed ID: 31903115)
1. Musashi-1 promotes stress-induced tumor progression through recruitment of AGO2.
Chen HY; Wang ML; Laurent B; Hsu CH; Chen MT; Lin LT; Shen J; Chang WC; Hsu J; Hung MC; Chen YW; Huang PI; Yang YP; Li CP; Ma HI; Chen CH; Lin WC; Chiou SH
Theranostics; 2020; 10(1):201-217. PubMed ID: 31903115
[TBL] [Abstract][Full Text] [Related]
2. Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastoma.
Chen HY; Lin LT; Wang ML; Lee SH; Tsai ML; Tsai CC; Liu WH; Chen TC; Yang YP; Lee YY; Chang YL; Huang PI; Chen YW; Lo WL; Chiou SH; Chen MT
Oncotarget; 2016 Jul; 7(27):42485-42501. PubMed ID: 27285760
[TBL] [Abstract][Full Text] [Related]
3. Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3.
Chen HY; Lin LT; Wang ML; Laurent B; Hsu CH; Pan CM; Jiang WR; Chen PY; Ma HI; Chen YW; Huang PI; Chiou A; Chiou SH
Sci Rep; 2017 Aug; 7(1):8710. PubMed ID: 28821879
[TBL] [Abstract][Full Text] [Related]
4. Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1.
Lan L; Appelman C; Smith AR; Yu J; Larsen S; Marquez RT; Liu H; Wu X; Gao P; Roy A; Anbanandam A; Gowthaman R; Karanicolas J; De Guzman RN; Rogers S; Aubé J; Ji M; Cohen RS; Neufeld KL; Xu L
Mol Oncol; 2015 Aug; 9(7):1406-20. PubMed ID: 25933687
[TBL] [Abstract][Full Text] [Related]
5. Musashi-1 promotes chemoresistant granule formation by PKR/eIF2α signalling cascade in refractory glioblastoma.
Chen HY; Lin LT; Wang ML; Tsai KL; Huang PI; Yang YP; Lee YY; Chen YW; Lo WL; Lan YT; Chiou SH; Lin CM; Ma HI; Chen MT
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1850-1861. PubMed ID: 29486283
[TBL] [Abstract][Full Text] [Related]
6. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
Liu X; Yang WT; Zheng PS
Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
[TBL] [Abstract][Full Text] [Related]
7. Strategic Decoy Peptides Interfere with MSI1/AGO2 Interaction to Elicit Tumor Suppression Effects.
Yang YP; Lee AC; Lin LT; Chen YW; Huang PI; Ma HI; Chen YC; Lo WL; Lan YT; Fang WL; Wang CY; Liu YY; Hsu PK; Lin WC; Li CP; Chen MT; Chien CS; Wang ML
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158774
[TBL] [Abstract][Full Text] [Related]
8. RNA binding protein Musashi-1 directly targets Msi2 and Erh during early testis germ cell development and interacts with IPO5 upon translocation to the nucleus.
Sutherland JM; Sobinoff AP; Fraser BA; Redgrove KA; Davidson TL; Siddall NA; Koopman P; Hime GR; McLaughlin EA
FASEB J; 2015 Jul; 29(7):2759-68. PubMed ID: 25782991
[TBL] [Abstract][Full Text] [Related]
9. Musashi-1 Enhances Glioblastoma Migration by Promoting ICAM1 Translation.
Lin JC; Tsai JT; Chao TY; Ma HI; Liu WH
Neoplasia; 2019 May; 21(5):459-468. PubMed ID: 30959276
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Musashi-1 enhances chemotherapeutic sensitivity in gastric cancer patient-derived xenografts.
Liu F; Yang H; Zhang X; Sun X; Zhou J; Li Y; Liu Y; Zhuang Z; Wang G
Exp Biol Med (Maywood); 2022 May; 247(10):868-879. PubMed ID: 35135374
[TBL] [Abstract][Full Text] [Related]
11. Msi1 promotes tumor progression by epithelial-to-mesenchymal transition in cervical cancer.
Gong P; Wang Y; Gao Y; Gao M; Liu L; Qu P; Jin X; Gao Q
Hum Pathol; 2017 Jul; 65():53-61. PubMed ID: 28088346
[TBL] [Abstract][Full Text] [Related]
12. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
13. The RNA-binding protein Musashi 1 stabilizes the oncotachykinin 1 mRNA in breast cancer cells to promote cell growth.
Nahas GR; Murthy RG; Patel SA; Ganta T; Greco SJ; Rameshwar P
FASEB J; 2016 Jan; 30(1):149-59. PubMed ID: 26373800
[TBL] [Abstract][Full Text] [Related]
14. Structural Insight into the Recognition of r(UAG) by Musashi-1 RBD2, and Construction of a Model of Musashi-1 RBD1-2 Bound to the Minimum Target RNA.
Iwaoka R; Nagata T; Tsuda K; Imai T; Okano H; Kobayashi N; Katahira M
Molecules; 2017 Jul; 22(7):. PubMed ID: 28753936
[TBL] [Abstract][Full Text] [Related]
15. A role for the ELAV RNA-binding proteins in neural stem cells: stabilization of Msi1 mRNA.
Ratti A; Fallini C; Cova L; Fantozzi R; Calzarossa C; Zennaro E; Pascale A; Quattrone A; Silani V
J Cell Sci; 2006 Apr; 119(Pt 7):1442-52. PubMed ID: 16554442
[TBL] [Abstract][Full Text] [Related]
16. Sequestration of microRNA-mediated target repression by the Ago2-associated RNA-binding protein FAM120A.
Kelly TJ; Suzuki HI; Zamudio JR; Suzuki M; Sharp PA
RNA; 2019 Oct; 25(10):1291-1297. PubMed ID: 31289130
[TBL] [Abstract][Full Text] [Related]
17. [Musashi-1 positively regulates growth and proliferation of hepatoma cells
Li J; Yan K; Yang Y; Li H; Wang Z; Xu X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Dec; 39(12):1436-1442. PubMed ID: 31907147
[TBL] [Abstract][Full Text] [Related]
18. The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis.
Vo DT; Subramaniam D; Remke M; Burton TL; Uren PJ; Gelfond JA; de Sousa Abreu R; Burns SC; Qiao M; Suresh U; Korshunov A; Dubuc AM; Northcott PA; Smith AD; Pfister SM; Taylor MD; Janga SC; Anant S; Vogel C; Penalva LO
Am J Pathol; 2012 Nov; 181(5):1762-72. PubMed ID: 22985791
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes.
Chen Y; Yang F; Fang E; Xiao W; Mei H; Li H; Li D; Song H; Wang J; Hong M; Wang X; Huang K; Zheng L; Tong Q
Cell Death Differ; 2019 Jul; 26(7):1346-1364. PubMed ID: 30341421
[TBL] [Abstract][Full Text] [Related]
20. The RNA-binding protein Musashi-1 is produced in the developing and adult mouse eye.
Raji B; Dansault A; Leemput J; de la Houssaye G; Vieira V; Kobetz A; Arbogast L; Masson C; Menasche M; Abitbol M
Mol Vis; 2007 Aug; 13():1412-27. PubMed ID: 17768378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
